Cleveland Clinic Rheumatology

Cleveland Clinic offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.

SLE Management: What Are the New Agents That Have Been Approved or Have Very Promising Preliminary Results? What Is the Challenge of Long-Lived Plasma Cells? What Are the Benefits of SGLT2i on Renal and Cardiovascular Outcomes?

By Cleveland Clinic Rheumatology FEATURING John Looney

334 views

July 27, 2021

Systemic Lupus Erythematosus webcast reviews treatment options for lupus nephritis.

The Basic and Clinical Immunology ...
read more ↘

Comments 0

Login

Login

Join VuMedi

Cleveland Clinic Rheumatology

SLE Management: What Are the New Agents That Have Been Approved or Have Very Promising Preliminary Results? What Is the Challenge of Long-Lived Plasma Cells? What Are the Benefits of SGLT2i on Renal and Cardiovascular Outcomes?

SLE Management: What Are the New Agents That Have Been Approved or H…

SLE: New Perspectives on Pathogenesis and Emerging Novel Therapies

Eye Disorders in Rheumatic Diseases: What Are the Recommendations on…

SLE With High Disease Activity & Potential Therapeutic Targets: Shou…

Managing Dermatologic Conditions in Rheumatology: How to Recognize a…

Advances in the Laboratory Aspects of Basic and Clinical Immunology …

A Primer on the Microbiome and Immune Health and Disease

Immunology for the Non-Immunologist: Understanding Immunology When Y…

Understanding B and T Cell Targeting in Autoimmune Diseases: Is Beli…

New and Emerging Treatments of Cutaneous Lupus

Advances in SLE and Vasculitis

Kinase Inhibition for IMIDs